Question 1

Who is Derek J. Maetzold?

Accepted Answer

Derek J. Maetzold serves as Executive at ENCYSIVE PHARMACEUTICALS INC (ENCY). They have executed 1319 insider transactions totaling $84.4M over their tenure at the company.

Question 2

What is Derek J. Maetzold's role at ENCYSIVE PHARMACEUTICALS INC?

Accepted Answer

Derek J. Maetzold holds the position of Executive at ENCYSIVE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.

Question 3

Is Derek J. Maetzold buying or selling ENCY stock?

Accepted Answer

Derek J. Maetzold has shown a selling trading pattern, with $0 in total purchases and $84.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are Derek J. Maetzold's largest insider transactions?

Accepted Answer

The largest transaction by Derek J. Maetzold was on Aug 15, 2022, when they sold $222.5K worth of CSTL shares. This transaction involved 6,665 shares at $33.38 per share.

Question 5

What is Derek J. Maetzold's trading accuracy?

Accepted Answer

Derek J. Maetzold has a Personal Accuracy Score of 98/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Derek J. Maetzold associated with?

Accepted Answer

Derek J. Maetzold has filed Form 4 transactions for 1 different company. Their primary association is with ENCYSIVE PHARMACEUTICALS INC (ENCY), where they serve as Executive.

Question 7

How much ENCY stock does Derek J. Maetzold own?

Accepted Answer

Derek J. Maetzold currently owns 87,715 shares of ENCYSIVE PHARMACEUTICALS INC (ENCY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Derek J. Maetzold's equity in ENCYSIVE PHARMACEUTICALS INC?

Accepted Answer

Derek J. Maetzold's equity position in ENCYSIVE PHARMACEUTICALS INC consists of 87,715 shares valued at approximately $0. As Executive, they have executed 1319 insider transactions, with $0 in purchases and $84.4M in sales.

Question 9

Where can I find Derek J. Maetzold's SEC Form 4 filings?

Accepted Answer

All of Derek J. Maetzold's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Derek J. Maetzold has 1319 Form 4 filings on record as an insider at ENCYSIVE PHARMACEUTICALS INC.

Question 10

What is Derek J. Maetzold's net worth from ENCY?

Accepted Answer

Based on their current ENCY stock holdings, Derek J. Maetzold has equity worth approximately $0 in ENCYSIVE PHARMACEUTICALS INC. This value is based on 87,715 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Aug 29, 2022	CSTL	$11.7K	Sale	396	$29.55	Discretionary
Aug 29, 2022	CSTL	$11.7K	Sale	396

Derek J. Maetzold

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Derek J. Maetzold Trading Summary

How Much ENCY Stock Does Derek J. Maetzold Own?

Is Derek J. Maetzold Buying or Selling ENCY?

Derek J. Maetzold's Recent Stock Transactions

Frequently Asked Questions

Track Derek J. Maetzold's Trades